Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | nizatidine | 3033637 | drug-path |
| Shigellosis | 0 | map05131 | nizatidine | 3033637 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | nizatidine | 3033637 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | spaglumic acid | 4189 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | epiandrosterone | 441302 | drug-path |
| Homologous recombination | R-HSA-5685942 | map03440 | epiandrosterone | 441302 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | epiandrosterone | 441302 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | epiandrosterone | 441302 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | dicloxacillin | 18381 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | dicloxacillin | 18381 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | dicloxacillin | 18381 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | dicloxacillin | 18381 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | dicloxacillin | 18381 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | dicloxacillin | 18381 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | dicloxacillin | 18381 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | dicloxacillin | 18381 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | dicloxacillin | 18381 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | dicloxacillin | 18381 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | dicloxacillin | 18381 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | ergocalciferol | 5280793 | drug-path |